Apogee Therapeutics IncNASDAQ:APGE
- LAST PRICE56.8500
- TODAY'S CHANGE (%)0.6200 (1.1026%)
- Bid / Lots51.9600/ 1
- Ask / Lots59.3200/ 1
- Open / Previous Close55.1800 / 56.2300
- Day Range
- 52 Week Range
- Volume224,127
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | APGE |
|---|---|---|
| 09:32 ET | 2157 | 55.18 |
| 09:34 ET | 2396 | 55.39 |
| 09:36 ET | 200 | 55.65 |
| 09:39 ET | 100 | 55.725 |
| 09:41 ET | 300 | 56.065 |
| 09:45 ET | 200 | 56.28 |
| 09:48 ET | 700 | 56.45 |
| 09:50 ET | 1316 | 55.95 |
| 09:52 ET | 100 | 55.95 |
| 09:54 ET | 100 | 56.13 |
| 09:56 ET | 200 | 56.24 |
| 09:57 ET | 100 | 56.175 |
| 09:59 ET | 100 | 56.14 |
| 10:01 ET | 500 | 55.97 |
| 10:03 ET | 100 | 56.0675 |
| 10:06 ET | 900 | 56.33 |
| 10:08 ET | 150 | 56.09 |
| 10:15 ET | 400 | 56.02 |
| 10:17 ET | 606 | 55.99 |
| 10:19 ET | 110 | 56.16 |
| 10:26 ET | 1803 | 56.22 |
| 10:28 ET | 100 | 56.275 |
| 10:32 ET | 300 | 56.21 |
| 10:33 ET | 263 | 56.26 |
| 10:39 ET | 100 | 56.38 |
| 10:42 ET | 600 | 55.94 |
| 10:44 ET | 300 | 55.825 |
| 10:46 ET | 100 | 55.75 |
| 10:50 ET | 100 | 55.75 |
| 10:55 ET | 100 | 55.96 |
| 10:57 ET | 100 | 55.985 |
| 11:00 ET | 100 | 55.99 |
| 11:02 ET | 100 | 55.76 |
| 11:06 ET | 207 | 55.74 |
| 11:09 ET | 2104 | 55.9 |
| 11:13 ET | 300 | 56.125 |
| 11:15 ET | 100 | 55.98 |
| 11:24 ET | 300 | 56.27 |
| 11:26 ET | 200 | 56.26 |
| 11:27 ET | 200 | 56.225 |
| 11:29 ET | 400 | 56.3796 |
| 11:31 ET | 1300 | 56.25 |
| 11:33 ET | 1119 | 56.25 |
| 11:38 ET | 800 | 56.43 |
| 11:42 ET | 100 | 56.44 |
| 11:44 ET | 300 | 56.575 |
| 11:45 ET | 100 | 56.535 |
| 11:47 ET | 4453 | 56.68 |
| 11:49 ET | 2153 | 57.01 |
| 11:51 ET | 300 | 57.09 |
| 11:54 ET | 300 | 57.005 |
| 11:56 ET | 1100 | 56.93 |
| 12:02 ET | 100 | 57.04 |
| 12:03 ET | 920 | 57.01 |
| 12:05 ET | 5563 | 57.59 |
| 12:07 ET | 200 | 57.795 |
| 12:09 ET | 100 | 57.795 |
| 12:12 ET | 5740 | 57.835 |
| 12:14 ET | 2721 | 57.515 |
| 12:16 ET | 121 | 57.515 |
| 12:18 ET | 1634 | 57.555 |
| 12:20 ET | 200 | 57.535 |
| 12:21 ET | 100 | 57.41 |
| 12:23 ET | 200 | 57.72 |
| 12:25 ET | 100 | 57.595 |
| 12:32 ET | 100 | 57.565 |
| 12:34 ET | 422 | 57.565 |
| 12:38 ET | 200 | 57.41 |
| 12:39 ET | 100 | 57.28 |
| 12:41 ET | 400 | 57.25 |
| 12:45 ET | 600 | 57.11 |
| 12:48 ET | 208 | 57.005 |
| 12:50 ET | 100 | 57.05 |
| 12:52 ET | 200 | 56.9 |
| 12:54 ET | 200 | 56.85 |
| 12:56 ET | 200 | 56.86 |
| 12:57 ET | 232 | 56.85 |
| 12:59 ET | 100 | 56.81 |
| 01:08 ET | 143 | 56.8 |
| 01:21 ET | 100 | 56.74 |
| 01:24 ET | 100 | 56.74 |
| 01:26 ET | 333 | 56.82 |
| 01:28 ET | 200 | 56.93 |
| 01:32 ET | 1100 | 56.75 |
| 01:35 ET | 100 | 56.77 |
| 01:39 ET | 200 | 56.71 |
| 01:42 ET | 1206 | 56.58 |
| 01:44 ET | 400 | 56.5 |
| 01:46 ET | 100 | 56.575 |
| 01:48 ET | 1200 | 56.73 |
| 01:51 ET | 200 | 56.695 |
| 01:53 ET | 200 | 56.655 |
| 01:57 ET | 600 | 56.53 |
| 02:00 ET | 200 | 56.555 |
| 02:04 ET | 403 | 56.48 |
| 02:06 ET | 220 | 56.47 |
| 02:09 ET | 200 | 56.81 |
| 02:13 ET | 100 | 56.785 |
| 02:15 ET | 100 | 56.78 |
| 02:24 ET | 302 | 56.62 |
| 02:27 ET | 100 | 56.685 |
| 02:31 ET | 938 | 56.575 |
| 02:33 ET | 1700 | 56.7 |
| 02:36 ET | 100 | 56.67 |
| 02:38 ET | 3212 | 56.71 |
| 02:45 ET | 300 | 57.0899 |
| 02:47 ET | 1100 | 56.97 |
| 02:49 ET | 1498 | 57.03 |
| 02:51 ET | 100 | 56.815 |
| 02:58 ET | 100 | 56.725 |
| 03:00 ET | 100 | 56.65 |
| 03:02 ET | 900 | 56.68 |
| 03:07 ET | 400 | 56.76 |
| 03:09 ET | 200 | 56.63 |
| 03:12 ET | 12208 | 56.585 |
| 03:14 ET | 300 | 56.645 |
| 03:16 ET | 800 | 56.57 |
| 03:18 ET | 200 | 56.575 |
| 03:21 ET | 200 | 56.54 |
| 03:23 ET | 400 | 56.71 |
| 03:25 ET | 100 | 56.735 |
| 03:27 ET | 900 | 56.7296 |
| 03:30 ET | 1000 | 56.705 |
| 03:34 ET | 904 | 56.9 |
| 03:36 ET | 100 | 57.1 |
| 03:39 ET | 200 | 57.05 |
| 03:41 ET | 100 | 56.81 |
| 03:45 ET | 200 | 56.95 |
| 03:50 ET | 503 | 57.0335 |
| 03:52 ET | 15415 | 57.3 |
| 03:54 ET | 3099 | 57.2 |
| 03:56 ET | 400 | 57.16 |
| 03:57 ET | 4801 | 56.86 |
| 03:59 ET | 45486 | 56.85 |
Sep 12, 2024
Apogee Therapeutics to Participate at the Stifel 2024 Immunology and Inflammation Summit, from 7:00AM ET on Thursday Sep 12, 2024 by Dow Jones
7:00AM ET on Thursday Sep 12, 2024 by Dow Jones
Sep 9, 2024
Apogee Therapeutics Appoints Jeff S. Hartness as Chief Commercial Officer, from 7:00AM ET on Monday Sep 09, 2024 by Dow Jones
7:00AM ET on Monday Sep 09, 2024 by Dow JonesPress Release: Apogee Therapeutics Appoints Jeff S. Hartness as Chief Commercial Officer, from 7:00AM ET on Monday Sep 09, 2024 by Dow Jones
7:00AM ET on Monday Sep 09, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Apogee Therapeutics Inc | 3.3B | -25.3x | --- |
MoonLake Immunotherapeutics | 3.3B | -57.5x | --- |
Xenon Pharmaceuticals Inc | 3.1B | -14.5x | --- |
Vitaspring Biomedical Co. Ltd | 3.1B | 3,311.3x | --- |
Dyne Therapeutics Inc | 3.6B | -9.4x | --- |
Iovance Biotherapeutics Inc | 3.0B | -5.8x | --- |
Company Information
Apogee Therapeutics, Inc. is a clinical-stage biotechnology company. The Company is engaged in developing differentiated biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), asthma and other inflammatory and immunology (I&I) indications with high unmet need. Its advanced programs are APG777 and APG808, which are developed for the treatment of AD and COPD, respectively. APG777 is a subcutaneous (SQ) extended half-life monoclonal antibody (mAb) targeting IL-13. APG808 is an SQ extended half-life mAb targeting IL-4Rα. Its earlier-stage programs, APG990 and APG222, utilize advanced antibody engineering to target OX40L and both IL-13 and OX40L, which are developed for the treatment of AD. APG990 is an SQ extended half-life mAb targeting OX40L for the treatment of AD. APG222 is one or more extended half-life SQ antibodies targeting both IL-13 and OX40L, which has the potential to improve outcomes in AD.
Contact Information
- Headquarters
- 221 Crescent St. Building 17, Suite 102bWALTHAM, MA, United States 02453
- Phone
- 650-394-5230
- Fax
- 302-655-5049
Executives
- Independent Chairman of the Board
- Mark Mckenna
- Chief Executive Officer, Director
- Michael Henderson
- Chief Financial Officer
- Jane Henderson
- Chief Medical Officer
- Carl Dambkowski
- Independent Director
- Lisa Bollinger
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $3.3B |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 58.5M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-2.25 |
Book Value | $7.86 |
P/E Ratio | -25.3x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
